TMS Co., Ltd Logo

TMS Co., Ltd

4891 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
府中市府中町一丁目9番地京王府中1丁目ビル11階
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

TMS Co., Ltd is a Japanese company focused on enhancing user experiences through advanced technology solutions. Leveraging innovative digital tools, TMS is dedicated to providing seamless browsing experiences for its clients and visitors. The company emphasizes the importance of user consent and data privacy, implementing cookie policies that ensure transparency in its digital engagements. TMS Co., Ltd strives to maintain high standards of service while adapting to the evolving landscape of technology, aiming to meet the diverse needs of its users effectively. With a commitment to quality and user satisfaction, TMS continues to be a significant player in the tech industry.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for TMS Co., Ltd. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-05-30 03:20
Regulatory News Service
臨時報告書
Japanese 27.5 KB
2025-05-30 03:18
Regulatory News Service
確認書
Japanese 7.9 KB
2025-05-30 03:17
Regulatory News Service
内部統制報告書-第21期(2024/03/01-2025/02/28)
Japanese 21.1 KB
2025-05-30 03:15
Annual Report
有価証券報告書-第21期(2024/03/01-2025/02/28)
Japanese 2.9 MB
2025-04-09 09:05
Regulatory News Service
臨時報告書
Japanese 19.9 KB
2025-03-14 07:58
Prospectus
有価証券届出書(組込方式)
Japanese 407.4 KB
2025-02-28 07:37
Regulatory News Service
臨時報告書
Japanese 18.5 KB
2025-02-06 09:01
Regulatory News Service
臨時報告書
Japanese 19.1 KB
2024-10-15 08:18
Regulatory News Service
確認書
Japanese 7.9 KB
2024-10-15 08:15
Interim Report
半期報告書-第21期(2024/03/01-2025/02/28)
Japanese 176.1 KB
2024-07-12 08:14
Regulatory News Service
確認書
Japanese 7.9 KB
2024-07-12 08:12
Quarterly Report
四半期報告書-第21期第1四半期(2024/03/01-2024/05/31)
Japanese 125.8 KB
2024-05-29 03:27
Regulatory News Service
確認書
Japanese 7.9 KB
2024-05-29 03:25
Regulatory News Service
内部統制報告書-第20期(2023/03/01-2024/02/29)
Japanese 21.1 KB
2024-05-29 03:23
Annual Report
有価証券報告書-第20期(2023/03/01-2024/02/29)
Japanese 2.8 MB

Automate Your Workflow. Get a real-time feed of all TMS Co., Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for TMS Co., Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BioLineRx Ltd. Logo
Biopharma firm developing and commercializing therapies for cancer and rare diseases.
Israel BLRX
BioMaxima S.A. Logo
Manufacturer of IVD solutions including tests, reagents, and equipment for medical labs.
Poland BMX
bioMérieux Logo
Provides in vitro diagnostic solutions for clinical and industrial microbiology.
France BIM
BioPorto Logo
IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.
Denmark BIOPOR
Biosynex Logo
European manufacturer of rapid diagnostic tests for professionals and consumer self-tests.
France ALBIO
Biotest AG Logo
Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.
Germany BIO3
Biotika A.S. Logo
Biotech producer of APIs like Penicillin for human & vet use, offering contract manufacturing.
Slovakia BSL
Bioton S.A. Logo
Develops and manufactures recombinant human insulin for global diabetes care solutions.
Poland BIO
BIOVENTIX PLC Logo
Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.
United Kingdom BVXP
Biovica International B Logo
Develops blood tests to monitor the efficacy of solid tumor cancer therapies.
Sweden BIOVIC